[{"Assets_0_Q1_USD":1913988000.0,"CommonStockSharesOutstanding_0_Q1_shares":19664.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":45258000.0,"NetIncomeLoss_1_Q1_USD":666337000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":20447000.0,"StockholdersEquity_0_Q1_USD":1079974000.0,"EarningsPerShareBasic_1_Q1_USD":32.59,"Ticker":"LGND","CIK":"886163","name":"LIGAND PHARMACEUTICALS INC","OfficialName":"Ligand Pharmaceuticals Incorporated Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1738856427.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190509"}]